Introduction
============

Irritable bowel syndrome (IBS) is a common functional gastrointestinal disorder (FGID), characterized by recurrent abdominal pain or discomfort associated with irregular bowel habits.^[@ref1]^ The reported mean prevalence of IBS ranges from 1.1% in France to 35.5% in Mexico.^[@ref2]^ The pathology underlying IBS is likely multifactorial resulting from a variety of mechanisms such as visceral hypersensitivity, motility disturbances, dysfunction of the gut-brain axis, genetic inheritance, low-grade inflammation, gut microbiome dysbiosis, and psychosocial disturbances.^[@ref3],[@ref4]^ Increasing numbers of epidemiological research associate pet or animal exposure with the development of IBS.^[@ref5]-[@ref7]^ A recent systematic review and meta-analysis combining the result of 5 studies found that exposure to pets was found to be significantly associated with having IBS (pooled odds ratio of 1.264).^[@ref5]^ In a prior community study performed in Singapore to investigate the environmental factors associated with IBS development, we found that pet owners were 2.5 times more likely to suffer from IBS.^[@ref6]^ Similarly, Koloski et al^[@ref7]^ also reported childhood animal exposure as a risk factor for the development of IBS later in life.

Multiple studies showed that patients with allergic diseases often also suffer from IBS, suggesting a link between atopic disorders and IBS.^[@ref8],[@ref9]^ In 2008, Tobin et al^[@ref9]^ showed that IBS was significantly more prevalent in patients with allergic rhinitis and allergic eczema. Atopic patients were also found to be 3.2 times more likely to fulfill IBS criteria compared to non-atopic patients, and were referred to as "atopic" IBS.^[@ref9]^ Vivinus-Nebot et al^[@ref10]^ showed that IBS patients with higher allergy-related factors like self-perception of adverse reaction to food, and blood eosinophilia were more prone to diarrhea than IBS patients with less allergy-related factors. In another study in Australia examining the relationship of atopy and FGIDs, self-reported animal allergy was significantly associated with IBS while pollen allergy was associated with functional dyspepsia.^[@ref11]^

Animal dander is one of many types of aeroallergens in addition to pollen, cockroach, and house dust mite (HDM). Aeroallergens have been shown to be involved in multiple gastrointestinal (GI) diseases. Allergic reactions to foods contaminated with HDM can cause oral mite anaphylaxis characterized by an immediate allergic reaction to mite in patients with IgE sensitization to HDM.^[@ref12]^ Eosinophilic esophagitis is an esophageal disease characterized by eosinophil-predominant inflammation. Intranasal instillation of dust mite, Aspergillus fumigatus, and cockroach causes the onset of experimental eosinophilic esophagitis.^[@ref13]^ Patients allergic to birch pollen often complain of both respiratory and GI symptoms during the birch pollen season. Studies of patients with birch pollen allergy have also shown that birch pollen exposure triggers a local inflammation in the duodenum with increased eosinophils and IgE-carrying mast cells (MCs).^[@ref14],[@ref15]^

However, not all studies reported positive results. Nybacka et al^[@ref16]^ reported that IBS patients did not have more atopic disease compared to controls (55.0% in IBS vs 40.0% in controls, *P* = 0.070). They also showed that atopy status or total serum IgE level was not a good biomarker to identify IBS patients with allergic manifestation. Thus, instead of looking for atopy in IBS based solely on IgE levels, we decided to establish the correlation between the complex and heterogenous atopic and allergic diseases with bowel issues by performing skin prick tests (SPTs), evaluation of specific IgE in serum by immune solid-phase allergen chip (ISAC) multiplex assay, and relating all of these results to pertinent clinical symptoms. We hypothesize that atopic patients with IBS-like symptoms are sensitized to animal dander. We aim to compare the sensitization pattern of aeroallergens and food allergens of both atopic patients with and without IBS-like symptoms.

Materials and Methods
=====================

Study Population
----------------

Study subjects comprised of consecutive adult Chinese patients seen for atopic symptoms (asthma, rhino-conjunctivitis, and/or atopic dermatitis) at the allergy outpatient clinic of the National University Hospital, Singapore. Exclusion criteria included patients with red flags (nocturnal GI symptoms, blood in stool, weight loss, recurrent fever, family history of colon cancer, or inflammatory bowel disease) or known organic GI disease, psychiatric illness, or any patient who has taken antibiotic, corticosteroids or immunosuppressive agents in the past 2 months. Participating subjects completed the Bowel Symptoms Questionnaire validated in our local setting,^[@ref17]^ underwent SPT and venipuncture for total serum IgE and specific IgE antibody tests. Blood was tested for occult parasitic infections to rule out their influence on total serum IgE level. Written informed consent was obtained from all subjects. The conduct of our study was approved by the local Institutional Review Board (NHG ROAM: 2011/02188).

Definition
----------

Rome III IBS was defined as recurrent abdominal pain or discomfort for at least 3 days per month in the last 3 months associated with at least 2 other criteria: (1) improvement with defecation; (2) onset associated with a change in frequency of stool; and (3) onset associated with a change in form of stool. Atopy was defined by the presence of atopic clinical symptoms (allergic rhinitis, asthma, and/or atopic dermatitis) plus either a positive SPT to at least one allergen and/or elevated total IgE in the presence of at least one positive specific IgE. Asthma was defined based on the criteria used in the European Community Respiratory Health Survey (ECRHS) II.^[@ref18]^ Allergic rhinitis was defined according to the Allergic Rhinitis and its Impact on Asthma (ARIA)^[@ref19]^ document, and allergic dermatitis was diagnosed based on the GA^2^LEN definition.^[@ref20]^ Pet ownership means the subject either currently or previously live in a home with indoor pet.

Skin Prick Test
---------------

SPTs were conducted by trained allergy nurses or physicians and evaluated by a board certified allergologist. All pricks were done on the volar aspect of the subjects' forearm and read 15 minutes after application. We used histamine (1 mg/mL) as our positive control, while physiological saline served as negative control (both from Allergopharma). The SPT was considered to be positive if the wheal diameter was larger than 3 mm. The SPT solutions used in our test panel were from Allergopharma (A), Germany and Stallergenes (S), France. They included: *Alternaria tenuis* (A), *Cladosporium herbarum* (A), *A. fumigatus* (A), *Penicillium notatum* (A), cockroach (A), grass mix (A; containing kentucky blue grass, meadow fescue, orchard grass, rye grass, timothy grass and velvet grass), tree mix I (A; containing alder, elm, hazel, poplar, and willow) and II (A; containing birch, beech, oak, and plane tree), grasses/cereals (A; containing grasses, barley, oat, rye, and wheat), weed pollens (A; containing \[*Artemisia vulgaris*, *Urtica dioica*, *Taraxacum vulgare*, and *Plantago lanceolata*\]), latex (A), *Dermatophagoides farinae* (A), *Dermatophagoides pteronyssinus* (A), *D. farinae* (S), *D. pteronyssinus* (S), *Blomia tropicalis* (S), dog (S), cat (S), prawn (S), curry (S), coffee (S), wheat (S), soya (S), and pork (S). HDM sensitization on SPT was measured using allergen extracts from Allergopharma and Stallergenes to compare the reproducibility of the standardized HDM allergens from different suppliers. The following drugs had to be avoided for at least 1 week before the SPTs: antihistamines, tricyclic antidepressants, cysteinyl leukotriene antagonists, benzodiazepines, and beta-blockers.

Specific Serum Immunoglobulin E Antibodies
------------------------------------------

Total serum IgE levels were measured using Phadia 100; results were reported in kIU/L. Specific serum IgE antibodies were measured with the ImmunoCAP ISAC (Thermo Fisher Scientific, Waltham, MA USA). ImmunoCAP ISAC is a miniaturized immunoassay platform that allows for multiplex measurement of specific IgE antibodies to many allergen components using 20 μL of serum or plasma. Allergens are immobilized on a microarray chip to allow simultaneous measurement of specific IgE antibodies to 112 components from 51 allergen sources.^[@ref21]^ Test results were measured with a biochip scanner and results were reported in ISAC standardized units (ISU) and categorized based on the manufacturer's cutoff levels (\< 0.3 ISU, undetectable or very low; 0.3-0.9 ISU, low; 1-14.9 ISU, moderate/high; and ≥ 15 ISU, very high). Values above 1 ISU were considered positive.

Statistical Methods
-------------------

The study sample size was chosen based on a previous population study from Singapore.^[@ref6]^ Descriptive statistics for the categorical variables were reported as number (%). Normally distributed continuous data were presented as mean and standard deviation. Categorical data were presented as mean and proportion. Categorical and continuous data were analyzed using chi-squared, unpaired t and Mann-Whitney *U* tests depending upon the distribution. All *P*-values were two-sided with the level of significance specified at 0.05. All analyses were performed using IBM SPSS version 25 (IBM Corp, Armonk, NY, USA).

Results
=======

Eighty-seven subjects who fulfilled the inclusion criteria were recruited. Sixty-nine subjects (female 52.2%) who fulfilled atopy criteria were included in the analysis. Twenty-eight (40.6%) atopic subjects fulfilled the Rome III IBS criteria (atopy-IBS). There was no difference in gender, age, type of housing, or education level between atopy-IBS and atopy-non-IBS group. There were more asthma patients in the atopy-IBS group (42.9% vs 14.6%, *P* = 0.014) but no difference in allergic rhinitis and allergic dermatitis ([Table 1](#T1){ref-type="table"}). There was a trend of increased pet ownership in the atopy-IBS group (75.0% vs 51.0% *P* = 0.068). There was no difference between types of animals at home and timing of the animals at home.

Skin Prick Tests
----------------

HDM antigens (*B. tropicalis*, *D. pteronyssinus*, and *D. farinae*) were the top 3 most sensitized antigens among all the participants. Thirty-five (50.7%) subjects were sensitized to dog dander and 28 (40.6%) to cat dander. Atopy-IBS patients had higher cat dander (64.3% vs 24.4%, *P* \< 0.001), dog dander (64.3% vs 41.5%, *P* = 0.015), and weed pollens (32.1% vs 14.6%, *P* = 0.050) sensitization compared to atopy-non-IBS patients ([Table 2](#T2){ref-type="table"}). Only 10 out of 28 participants who were tested positive for cat dander did not have IBS-like symptoms. Eighteen atopy-IBS patients had cat dander sensitization, majority had mixed-type IBS (7/18), followed by diarrhea-predominant IBS (4/18), constipation-predominant IBS (4/18), and unsubtyped IBS (3/18). Sixteen of cat dander sensitized atopy-IBS subjects had AR, 8 had asthma and 7 had eczema. Majority of atopy-IBS with cat dander sensitization do not have animals at home. Only 4 had cats and 6 had dogs at home.

Specific Serum Immunoglobulin E Antibodies
------------------------------------------

Out of 112 components from 51 allergen sources, only Fel d1 (major cat dander antigen) sensitization was significantly higher in the atopy-IBS group (21.4% vs 2.4%, *P* = 0.029) ([Table 3](#T3){ref-type="table"}). Only 1 Fel d1 positive patient out of 7 had no IBS symptoms. All Fel d1 positive patients had allergic rhinitis, 50.0% of them had asthma and eczema. The only Fel d1 positive patient with no IBS symptoms had positive cat SPT, allergic rhinitis, and eczema, while the only positive GI symptom in this patient was hard stool.

Discussion
==========

Comparing atopic patients with or without IBS-like symptoms, we found a significant association between animal danders and weed pollen (*A. vulgaris*, *U. dioica*, *T. vulgare*, and *P. lanceolate*) sensitization and IBS-like symptoms. However only cat dander sensitization was significantly higher in both SPT and specific IgE tests. It is important to state early that the demonstration of animal dander sensitization purely based on positive SPTs and specific IgE is not sufficient to diagnose a clinically relevant allergy. A sensitized individual may be entirely asymptomatic upon exposure to the allergen in question. To prove causation, we will need to show that exposure to the culprit allergen reproduces IBS symptoms. Our study hinted that aeroallergens may have a more sinister role in the GI tract rather than just being an innocent bystander. Notably, our findings concur with the recent report by Koloski et at^[@ref11]^ that patients with self-reported animal allergy had higher prevalence of IBS.

Aeroallergens and the Gastrointestinal Tract
--------------------------------------------

The possible role of aeroallergens in the distal area of the GI tract was first raised after the discovery of HDMs allergen in the colon by Tulic et al.^[@ref22]^ The cysteine protease activity of Der p1 resulted in increased epithelial permeability.^[@ref16]^ Previously, the role of aeroallergens was sidelined by food allergy in IBS studies. In retrospect, multiple studies that looked for food allergy or relationship of IBS and allergy often included aeroallergens as part of their routine investigation, and some had reported higher aeroallergen sensitization in IBS compared to their respective controls. Vivinus-Nebot et al^[@ref10]^ showed that IBS patients had significantly higher aeroallergen sensitization, enhanced colonic permeability, a higher number of MCs, and spontaneous release of tryptase than healthy subjects. Though Nybacka et al^[@ref16]^ did not find a higher prevalence of IBS in atopic patients, they showed that a higher proportion of atopic IBS patients tested positive for aeroallergens, as compared to non-atopic IBS patients.

Cat Dander Sensitization
------------------------

Cats release proteins into the environment through excretion or as dander, minute scales from hair, skin, saliva, or urine. Fel d1, a major cat allergen, is found in cat saliva, sebaceous glands, and urine. Fel d1 elicits IgE responses in 90.0% to 95.0% of patients with cat allergy. The prevalence of cat dander sensitization is in the range of 10.0% to 15.0% among adults worldwide.^[@ref23]-[@ref25]^ Exposure to cat allergens can happen without us knowing, as cat allergens are known to persist up to 6 months after the source is removed. They easily become airborne and attach themselves to hair or clothing. Generally, there is a direct relationship between exposure and immune response to allergens like pollen, cockroach, and HDM. Conversely, high exposure to cat dander has been associated with an induction of tolerance instead.^[@ref25]-[@ref28]^

High exposure to cat dander induces a tolerogenic signal mediated by IL-10 and TGF-β secreted by T-regulators, which results in suppression of allergy effector cells including MCs, basophils, and eosinophils. It is postulated that increased gut permeability reported in some IBS patients may lead to higher concentrations of the allergen being delivered to antigen-presenting cells.^[@ref29]-[@ref31]^ We postulate that IBS patients may have 2 reasons for high cat dander sensitization: (1) IBS patients have an impaired mucosal barrier thus enabling cat dander to cross the gut epithelium,^[@ref32],[@ref33]^ and (2) IBS patients exhibit an immune imbalance favoring the production of pro-inflammatory TNF-α over the anti-inflammatory IL-10 cytokines leading to failure of developing "immunological tolerance."^[@ref34]-[@ref36]^ The presence of sensitization to cat dander in these patients may be a reflection of these processes and may be a biomarker of disease, at least for a subtype of patients.

Effect of Anti-allergic Drugs on Irritable Bowel Syndrome
---------------------------------------------------------

Anti-allergic drugs have previously been evaluated in IBS patients, though mostly by chance and not targeting the allergy process. A study by Lobo et al^[@ref37]^ showed that both MC activation and IBS symptoms decreased in diarrhea-predominant IBS patients treated with oral disodium cromoglycate compared to those without treatment. In a randomized control trial, ketotifen was shown to increase discomfort threshold in IBS patients with visceral hypersensitivity.^[@ref38]^ Ebastine, a second-generation H1-antihistamine, was effective in reducing visceral hypersensitivity and abdominal pain in IBS patients.^[@ref39]^

Our study is limited by the relatively small number of subjects. We also lack data on psychosocial factors which can shed light on the effect of psychological attributes on clinical severity. It would have been desirable to verify exposure-based symptoms to assess the clinical relevance of sensitization and its relationship with other allergic diseases. However, a single question is unlikely to ascertain the degree of animal exposure, and more thorough questioning on animal exposure had been suggested.

Conclusion
==========

We demonstrated an association between aeroallergen sensitization, in particular animal dander sensitization, and IBS-like symptoms in atopic patients. This observation warrants further study to assess the clinical relevance of such sensitization through a more granular comprehensive clinical history and closer examination to assess whether exposure to cat allergen reproduces IBS symptoms or we have been missing aeroallergen-induced gut allergy.

We would like to take the opportunity to thank Reuben Wong, Lee Keat Hong, Juanda Leo Hartono, Low How Cheng, David Ong, and the colleagues of Division of Rheumatology and Allergy for their assistance and contribution to the study.

**Financial support:** This study was supported by a grant of National University Health System Juniors Research (Grant No. 05/12).

**Conflicts of interest:** None.

**Author contributions:** Study conception, design and oversight, data collection, data interpretation, drafting of the manuscript, critical review, and revision of manuscript: Kewin T H Siah; study conception, design and oversight, data interpretation, critical review, and revision of manuscript: Amelia Santosa; critical review and revision of the manuscript: Cynthia K Cheung; data analysis, critical review, and revision of the manuscript: Alex Y S Soh; and design and oversight, critical review, and revision of manuscript: Paul L Bigliardi.

###### 

Characteristics of Atopic Subjects With and Without Irritable Bowel Syndrome-like Symptoms

  Variables                                         Atopy-non-IBS n (%)   Atopy-IBS n (%)   *P*-value
  ------------------------------------------------- --------------------- ----------------- -----------
  Total                                             41 (59.4)             28 (40.6)         
  Female                                            19 (46.3)             17 (60.7)         0.270
  Age (mean \[SD\], yr)                             35.1 (12.3)           33.5 (11.3)       0.492
  Type of housing[a](#t1fn1){ref-type="table-fn"}   0.074                                   
  Government flat                                   31 (75.6)             20 (71.4)         
  Private apartment                                 2 (4.9)               6 (21.4)          
  Land property                                     7 (17.1)              2 (7.1)           
  Highest education                                 0.134                                   
  Primary                                           0 (0.0)               1 (3.6)           
  Secondary                                         15 (36.6)             5 (17.9)          
  Tertiary or higher                                26 (63.4)             22 (78.6)         
  Pet ownership                                     26 (51.0)             21 (75.0)         0.068
  Asthma                                            6 (14.6)              12 (42.9)         0.014
  Allergic rhinitis                                 36 (87.8)             25 (89.3)         0.200
  Eczema                                            22 (53.7)             10 (35.7)         0.183
  Serum total IgE (mean \[SD\], kIU/L)              148.8 (190.8)         211.5 (224.5)     0.232
  Histamine size (mean \[SD\], mm)                  4.8 (1.2)             5.0 (0.9)         0.274

Missing 1 entry for type of housing.

IBS, irritable bowel syndrome; IgE, Immunoglobulin E.

###### 

Frequency of Sensitization to Aeroallergens by Skin Prick Test

  Aeroallergens                      Total SPT positive (n = 69)   Atopy-non-IBS (n = 41)   Atopy-IBS (n = 28)   *P*-value
  ---------------------------------- ----------------------------- ------------------------ -------------------- -----------
  *Alternaria tenuis*                5 (7.2)                       3 (7.3)                  2 (7.1)              0.762
  *Aspergillus fumigatus*            4 (5.8)                       2 (4.9)                  2 (7.1)              0.908
  *Blomia tropicalis*                56 (81.2)                     33 (80.5)                23 (82.1)            0.454
  *Cladosporium herbarum*            5 (7.2)                       3 (7.3)                  2 (7.1)              0.762
  *Dermatophagoides farinae*         54 (78.3)                     30 (73.2)                24 (85.7)            0.172
  *Dermatophagoides pteronyssinus*   56 (81.2)                     32 (78.0)                24 (85.7)            0.439
  *Penicillium notatum*              5 (7.2)                       2 (4.9)                  3 (10.7)             0.830
  Cockroach                          42 (60.9)                     21 (51.2)                21 (75.0)            0.268
  Dog dander                         35 (50.7)                     17 (41.5)                18 (64.3)            0.015
  Cat dander                         28 (40.6)                     10 (24.4)                18 (64.3)            \< 0.001
  Weed pollen                        15 (21.7)                     6 (14.6)                 9 (32.1)             0.050

SPT, skin prick test; IBS, irritable bowel syndrome; IgE, immunoglobulin E.

Data are presented as number (%).

###### 

Frequency of Sensitization to Aeroallergens by Immune Solid-phase Allergen Chip[a](#t3fn1){ref-type="table-fn"}

  Common name       Latin name (allergen component)               Total ISAC positive (n = 68)   Atopy-non-IBS (n = 41)   Atopy-IBS (n = 28)   *P*-value
  ----------------- --------------------------------------------- ------------------------------ ------------------------ -------------------- -----------
  Aspergillus       *Aspergillus fumigatus* (rAsp f 3)            1 (1.5)                        0 (0)                    1 (3.6)              0.326
  Bermuda grass     Cynodon dactylon (nCyn d 1)                   2 (2.9)                        0 (0)                    2 (7.1)              0.337
  Birch             Betula verrucose (Betv1)                      2 (2.9)                        0 (0)                    2 (7.1)              0.170
  House dust mite   *Dermatophagoides farina* (rDer f 1)          34 (50)                        21 (51.2)                13 (46.4)            0.568
  House dust mite   *Dermatophagoides pteronyssinus* (nDer p 1)   33 (48.5)                      20 (48.8)                13 (46.4)            0.959
  Timothy-grass     Phleum pretense (rPhl p 1)                    4 (5.9)                        2 (4.9)                  2 (7.1)              0.696
  Dog               Canis famillaris (rCan f 1)                   4 (5.9)                        2 (4.9)                  2 (7.1)              0.856
  Horse             Equus caballus (nEqu c 3)                     1 (1.5)                        1 (2.4)                  0 (0.0)              0.817
  Cat               Felis domesticus (rFel d 1)                   7 (10.3)                       1 (2.4)                  6 (21.4)             0.029
  Cat               Felis domesticus (rFel d 4)                   3 (4.4)                        1 (2.4)                  2 (7.1)              0.553
  Mouse             Mus musculus (nMus m 1)                       2 (2.9)                        1 (2.4)                  1 (3.6)              0.807

Missing 1 subject's immune solid-phase allergen chip (ISAC) result.

IBS, irritable bowel syndrome.

Data are presented as number (%).
